FDA product code SBQ: Atrial Fibrillation Risk Prediction Machine Learning-Based Notification Software

SBQ is the FDA product code for atrial fibrillation risk prediction machine learning-based notification software. It is a Class II device, regulated under 21 CFR 870.2380 and reviewed by the Cardiovascular panel. FDA has cleared 2 510(k) submissions under SBQ, 2 in the last five years. The average 510(k) review took 250 days (median 250); 250 days on average over the last three years.

Definition

Atrial Fibrillation Risk Prediction machine learning-based notification software employs machine learning techniques to suggest the likelihood of a future occurrence of atrial fibrillation for further referral or diagnostic follow-up.

Classification

FieldValue
Device nameAtrial Fibrillation Risk Prediction Machine Learning-Based Notification Software
Device classClass II
Regulation21 CFR 870.2380
Review panelCV — Cardiovascular
Medical specialtyCardiovascular
Premarket route510(k)

510(k) clearances per year for SBQ

YearClearancesAvg. review days
20241231
20261268

Compare with all 510(k) review times · Search every SBQ clearance

Top SBQ applicants

ApplicantClearancesLatest
Tempus AI, Inc.22026-09-25

Most recent SBQ clearances

510(k)ApplicantDeviceDecision dateReview days
K254297Tempus AI, Inc.Tempus ECG-MR2026-09-25268
K233549Tempus AI, Inc.Tempus ECG-AF2024-06-21231

Recalls for SBQ devices

FDA recall records list no recalls for product code SBQ.

Frequently asked questions

What is FDA product code SBQ?

SBQ is the FDA product code for atrial fibrillation risk prediction machine learning-based notification software. It is a Class II device, regulated under 21 CFR 870.2380 and reviewed by the Cardiovascular panel.

What device class is SBQ?

Class II, regulation 21 CFR 870.2380. Typical premarket route: 510(k).

How long does a 510(k) take for product code SBQ?

Across 2 cleared submissions the average was 250 days from receipt to decision (median 250).

Which companies have the most SBQ clearances?

Tempus AI, Inc. (2).

Next steps

Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.

All Cardiovascular product codes · FDA product code lookup · 510(k) database search · 510(k) review times